Publication | Closed Access
Delayed HBV reactivation in rituximab-containing chemotherapy: How long should we continue anti-virus prophylaxis or monitoring HBV-DNA?
47
Citations
8
References
2016
Year
Delayed Hbv ReactivationOncologyRituximab-containing ChemotherapyViral PersistenceAntiviral TherapyHepatitisVirologyAnti-virus ProphylaxisAntiviral DrugChronic Viral InfectionMedicine
| Year | Citations | |
|---|---|---|
Page 1
Page 1